The Pfizer Inc. rises Tuesday, but is still underperforming the market

by

Shares of Pfizer Inc. PFE,
+ 0.08%
fell 0.08% higher to $ 36.73 Tuesday, on what turned out to be an all-round favorable trading session for the stock market, with the S&P 500 Index SPX,
+ 0.81%
up 0.81% to 3,798.91 and the Dow Jones Industrial Average DJIA,
+ 0.38%
increases by 0.38% to 30,930.52. The stock’s rise broke a four-day loss streak. Pfizer Inc. closed down $ 6.35 from its 52-week high of $ 43.08, which the company hit on Dec. 9.

The stock performed mixed compared to some of its competitors on Tuesday, such as Johnson & Johnson JNJ,
+ 1.55%
rose 1.55% to $ 162.78, Merck & Co. Inc. MRK,
-0.23%
declined 0.23% to $ 83.19, and Novartis AG ADR NVS,
+ 1.11%
increased 1.11% to $ 96.69. The trade volume (33.3 million) remained 16.5 million below the 50-day average volume of 49.8 million.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

.Source